• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, November 19, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

Vitamin E TPGS emulsified vinorelbine bitartrate loaded solid lipid nanoparticles (SLN)

Bioengineer by Bioengineer
December 16, 2018
in Cancer
Reading Time: 2 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

This article by Dr. Sanjay Singh et al. is published in Current Drug Delivery, Volume 15 , Issue 8 , 2018

IMAGE

Credit: Dr. Sanjay Singh, Bentham Science Publishers

Vinorelbine Bitartrate (VRL), a semi-synthetic vinca alkaloid was approved by the FDA for breast cancer treatment, as it has been proven to be beneficial for first line of defense and subsequent therapies. But its hydrophilic and thermolabile structure causes hindrance to oral clinical translation. The main objective of this research is the development and optimization of a solid lipid nanoparticle (SLN) structure that can encapsulate hydrophilic and thermolabile Vinorelbine bitartrate to maximize the anticancer activity of the drug without compromising its efficacy and integrity. For this purpose, the study is mainly focused on the application of DOE, a modern statistical optimization tool for nanoparticle modification.

To prepare SLNs, a solvent diffusion technique was used employing Taguchi orthogonal array design with process variables and optimized formulation. Glyceryl mono-oleate (GMO) were used for its emulsifying nature and low melting point to enhance entrapment and reducing temperature associated degradation. To prevent infection, two types of surfactants, Vitamin E TPGS, and Poloxamer-188 were used to obtain TPGS-VRL-SLNs and PL-VRL-SLNs.

The results proved the method to be effective. The SLNs were produced spherical in shape with entrapment efficiency (EE) upto 58%. A biphasic release pattern was observed in in vitro release studies followed by the Korsemeyer peppas model with fickian release kinetics. MTT assay results revealed that TPGS-VRL-SLNs and PL-VRL-SLNs were 39.5 and 18.5 time more effective than VRL in its original nature. The DOE method was believed to be a successful approach for development of VRL-SLNs. Enhanced entrapment with anticancer efficacy of TPGS-VRL-SLN was the result of emulsifying nature of GMO and the cytotoxic nature of TPGS which influences VRL effects. Such properties of TPGS-VRL-SLNs may prove them to be a potentially useful carrier in cancer chemotherapeutics.

###

This article is Open Access. To obtain the article please visit: http://www.eurekaselect.com/161120

Media Contact
Faizan ul Haq
faizan@benthamscience.net

Related Journal Article

http://dx.doi.org/10.2174/1567201815666180409105410

Tags: BiochemistryBioinformaticsBreast CancercancerCarcinogensMedicine/HealthPharmaceutical SciencesPharmaceutical/Combinatorial ChemistryToxicology
Share12Tweet8Share2ShareShareShare2

Related Posts

Fluorescent Tracer Improves Sentinel Lymph Node Detection in Early Breast Cancer Trial

Fluorescent Tracer Improves Sentinel Lymph Node Detection in Early Breast Cancer Trial

November 19, 2026
Urogenital Microbiota Shifts Link to Cancer Progression and Immunotherapy Outcomes

Urogenital Microbiota Shifts Link to Cancer Progression and Immunotherapy Outcomes

November 19, 2026

European Consortium Secures Funding to Advance Dark Antigen Liver Cancer Vaccines

November 19, 2026

Trilaciclib Targets NUAK2 RNA Splicing Vulnerability in Aggressive Prostate Cancer

November 19, 2026
Please login to join discussion

POPULAR NEWS

  • No Metabolic Crises Occurred With Peripartum Dextrose in Small Observational Study

    No Metabolic Crises Occurred With Peripartum Dextrose in Small Observational Study

    29 shares
    Share 12 Tweet 7
  • Mental Health Emergency Visits in Saudi Arabia Surge During Late Autumn and Winter

    29 shares
    Share 12 Tweet 7
  • Rare APBA1 Genetic Variants Identified in Children with Severe Monogenic Obesity

    29 shares
    Share 12 Tweet 7
  • RNA Thermometer Controls Recombinant Protein Expression in Engineered Escherichia Coli Cultures

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Pune Cash Aid Beneficiaries Report High Perceived Independence but Limited Asset Ownership

Meta-Analysis Identifies Graft Elongation as Distinct Mode of ACL Reconstruction Failure

Acoustic Chaos and Entropy Metrics Track Laboratory Fatigue Damage in Asphalt Beams

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 89 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.